Literature DB >> 17380785

Strategies to modulate cellular energetic metabolism during sepsis.

Alessandro Protti1, Mervyn Singer.   

Abstract

Growing evidence suggests that mitochondrial inhibition plays a major role in the development of multiple organ failure during sepsis. Early correction of tissue hypoxia, strict control of glycaemia and modulation of oxidative and nitrosative stress may protect mitochondria during the acute inflammatory response. Once mitochondrial dysfunction has developed, the regulated induction of a hypometabolic state, analogous to hibernation, may protect the cells from severe bioenergetic failure and a critical fall in ATP. Though this is clinically manifest as organ dysfunction, it may actually represent an adaptive response to a prolonged, severe inflammatory stress. Repair of damaged organelles, stimulation of mitochondrial biogenesis and re-activation of cellular metabolism may accelerate the recovery phase and thus improve clinical outcomes. The aim of this review is to discuss putative interventions aimed at preventing or reversing mitochondrial dysfunction that may have possible clinical relevance, and to stress the importance of the correct timing of intervention.

Entities:  

Mesh:

Year:  2007        PMID: 17380785

Source DB:  PubMed          Journal:  Novartis Found Symp        ISSN: 1528-2511


  11 in total

1.  NETWORKS, BIOLOGY AND SYSTEMS ENGINEERING: A CASE STUDY IN INFLAMMATION.

Authors:  P T Foteinou; E Yang; I P Androulakis
Journal:  Comput Chem Eng       Date:  2009-12-10       Impact factor: 3.845

2.  Endotoxemia impairs heart mitochondrial function by decreasing electron transfer, ATP synthesis and ATP content without affecting membrane potential.

Authors:  Virginia Vanasco; Natalia D Magnani; María Cecilia Cimolai; Laura B Valdez; Pablo Evelson; Alberto Boveris; Silvia Alvarez
Journal:  J Bioenerg Biomembr       Date:  2012-03-18       Impact factor: 2.945

3.  Agent-based modeling of endotoxin-induced acute inflammatory response in human blood leukocytes.

Authors:  Xu Dong; Panagiota T Foteinou; Steven E Calvano; Stephen F Lowry; Ioannis P Androulakis
Journal:  PLoS One       Date:  2010-02-18       Impact factor: 3.240

4.  Modeling endotoxin-induced systemic inflammation using an indirect response approach.

Authors:  P T Foteinou; S E Calvano; S F Lowry; I P Androulakis
Journal:  Math Biosci       Date:  2008-09-20       Impact factor: 2.144

Review 5.  Sepsis-induced myopathy.

Authors:  Leigh Ann Callahan; Gerald S Supinski
Journal:  Crit Care Med       Date:  2009-10       Impact factor: 7.598

6.  May "mitochondrial eve" and mitochondrial haplogroups play a role in neurodegeneration and Alzheimer's disease?

Authors:  Elena Caldarazzo Ienco; Costanza Simoncini; Daniele Orsucci; Loredana Petrucci; Massimiliano Filosto; Michelangelo Mancuso; Gabriele Siciliano
Journal:  Int J Alzheimers Dis       Date:  2011-02-22

Review 7.  Bench-to-bedside review: Hydrogen sulfide--the third gaseous transmitter: applications for critical care.

Authors:  Florian Wagner; Pierre Asfar; Enrico Calzia; Peter Radermacher; Csaba Szabó
Journal:  Crit Care       Date:  2009-06-03       Impact factor: 9.097

8.  Experimental assessment of bioenergetic differences caused by the common European mitochondrial DNA haplogroups H and T.

Authors:  Taku Amo; Nagendra Yadava; Richard Oh; David G Nicholls; Martin D Brand
Journal:  Gene       Date:  2008-01-26       Impact factor: 3.688

9.  Platelet mitochondrial dysfunction in critically ill patients: comparison between sepsis and cardiogenic shock.

Authors:  Alessandro Protti; Francesco Fortunato; Andrea Artoni; Anna Lecchi; Giovanna Motta; Giovanni Mistraletti; Cristina Novembrino; Giacomo Pietro Comi; Luciano Gattinoni
Journal:  Crit Care       Date:  2015-02-11       Impact factor: 9.097

10.  Associations of mitochondrial haplogroups b4 and e with biliary atresia and differential susceptibility to hydrophobic bile Acid.

Authors:  Mao-Meng Tiao; Chia-Wei Liou; Li-Tung Huang; Pei-Wen Wang; Tsu-Kung Lin; Jin-Bor Chen; Yao-Min Chou; Ying-Hsien Huang; Hung-Yu Lin; Chao-Long Chen; Jiin-Haur Chuang
Journal:  PLoS Genet       Date:  2013-08-15       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.